Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders. - Test2 - elhamkhani - TriplyDB

Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.

Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.

http://www.wikidata.org/entity/Q33972726

about

Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research.Neurosteroids Involvement in the Epigenetic Control of Memory Formation and Storage.Editorial on "New perspectives in neurosteroids action: a special player allopregnanolone".Allopregnanolone attenuates Aβ25-35-induced neurotoxicity in PC12 cells by reducing oxidative stress.Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers.Novel analogs of allopregnanolone show improved efficiency and specificity in neuroprotection and stimulation of proliferation.Neurosteroids in Pain Management: A New Perspective on an Old Player

P2860

Q27338799-6C474513-A0E6-4391-B0CA-2161188CD0A9 Q28394967-79C4D8BE-C9D4-47A2-984B-D2F0B064819C Q35650967-455E9CBF-B6C5-4C6E-92D6-F5A311F7B305 Q36626032-AF276012-EE3E-4A7F-8A29-139D2748F3B3 Q37549551-8E5307C9-F91A-4C00-962C-A6BF1540314D Q39434865-A5387AAA-04E3-4D28-B28C-06C78DF5A8BE Q43209931-FED206C4-944E-4962-843A-8F7C99310E05 Q46017473-8333E646-32DE-4B75-8BBE-F49E9EA13FE2 Q47424155-BE72263E-0641-45C8-98AF-00401F59F3EA Q58586871-F3D8FB77-6931-4AC1-A2CE-EA909D5833EC

P2860

Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.

http://www.wikidata.org/entity/Q33972726

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Frontiers in therapeutic devel ...... other neurological disorders.

@ast

Frontiers in therapeutic devel ...... other neurological disorders.

@en

type

label

Frontiers in therapeutic devel ...... other neurological disorders.

@ast

Frontiers in therapeutic devel ...... other neurological disorders.

@en

prefLabel

Frontiers in therapeutic devel ...... other neurological disorders.

@ast

Frontiers in therapeutic devel ...... other neurological disorders.

@en

P1433

Q33972726-5517A13A-85C6-47FD-AFE7-A21E878D689A

P1476

Q33972726-62740230-C724-4309-9A74-E730605080B4

P2093

Q33972726-6E82E984-BC4C-4DB2-A0BD-53ED75C57279

Q33972726-948EDFBE-308E-4989-98B6-B282CB98E335

Q33972726-A2CED204-D2D0-44C7-8C4D-9C3465D29C92

P2860

Q33972726-01DC4EAD-DB8A-4F0D-99AE-90B0B4B36322

Q33972726-02BAA549-5004-47A6-8EE0-3A93D8D0C45A

Q33972726-04D2A56A-4A57-4ED7-8561-49D7B4D2D192

Q33972726-0741297A-A2E6-495D-966E-CD4C21B37EAD

Q33972726-088E7BAF-1FBE-4592-983E-307A6818213F

Q33972726-08C06BE0-00DB-40F3-B403-E7FE8EB22CD1

Q33972726-0ADEBEF8-F13E-4B3B-AF63-62AA3B46BAFF

Q33972726-0BD71CCA-71D8-4D7A-A0EB-0B0C30EAA36A

Q33972726-0CF069D4-662E-4530-8397-9B9BB08BF278

Q33972726-0D74563F-097E-41CA-A7E0-632AD39A518A

P304

Q33972726-3B80B15E-BE3F-467E-9205-6AFC6B219C55

P31

Q33972726-BC8A6E5F-7846-4BDC-93F4-0067F5CB3C32

P356

Q33972726-3C7D5CA7-D747-4E78-928D-37744B23D8A4

P478

Q33972726-F7B09F89-5C41-44C6-BCE7-C64C01C34300

P577

Q33972726-49169D64-AE80-4F1B-9AC6-BA223382DF24

P5875

Q33972726-3AE82B7D-6EF5-4183-A251-6AF19D82E89D

P698

Q33972726-E20CB14A-1A98-4812-A1DE-D67AC808A770

P921

Q33972726-603DC777-4F0F-4884-8474-A890C0FDE650

P932

Q33972726-E020BD3B-B941-41A6-BCB1-B256E32190CA

P356

FNCEL.2014.00203

P1433

Frontiers in Cellular Neuroscience

P1476

Frontiers in therapeutic devel ...... other neurological disorders.

@en

P2093

Christine M Solinsky

http://www.w3.org/2001/XMLSchema#string

Roberta Diaz Brinton

http://www.w3.org/2001/XMLSchema#string

Ronald W Irwin

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of recombinant gamma-aminobutyric acid (GABA)(A) and GABA(C) receptors by protein kinase C

Role of LXRs in control of lipogenesis

Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease

Endogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C disease

ApoE promotes the proteolytic degradation of Abeta

Neurosteroid regulation of central nervous system development

Molecular targets for antiepileptic drug development

Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease

P304

203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNCEL.2014.00203

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264832925

http://www.w3.org/2001/XMLSchema#string

P698

25126056

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4115668

http://www.w3.org/2001/XMLSchema#string